ID   UCLAi004-A
SY   MZT06-B; MZT06B
DR   hPSCreg; UCLAi004-A
DR   Wikidata; Q107117195
RX   PubMed=34216981;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Caucasian.
CC   Miscellaneous: Established from monozygotic twin of UCLAi001-A (CVCL_WT92), UCLAi001-B (CVCL_WT93) and UCLAi001-C (CVCL_WT94).
CC   Derived from sampling site: Skin; dermis.
ST   Source(s): PubMed=34216981
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 32.2
ST   D3S1358: 12
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 23-09-21; Version: 2
RX   PubMed=34216981; DOI=10.1016/j.scr.2021.102446;
RA   Pandolfi E.C., Hunt T.J., Goldsmith S., Hurlbut K., Silber S.J.,
RA   Clark A.T.;
RT   "Generation of three human induced pluripotent stem cell sublines
RT   (UCLAi004-A, UCLAi004-B, and UCLAi004-C) for reproductive science
RT   research.";
RL   Stem Cell Res. 54:102446-102446(2021).